Clinica Alma Res
Roma, 00198, Italy
NCT Number: NCT05625308
To test the efficacy of a newly-commercialized formula, 40 HPV-positive women displaying chronic cervicitis, mild dysplasia or moderate dysplasia. Women in the study group took one tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid for twelve weeks. Women in the control group received no treatment.
Looking for future studies?
Notify Me18 year–55 year
Female
Interventional
Not applicable
Roma, 00198, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid.
Time frame: 12 weeks
The actual outcome was to measure the rate of regression of the lesions, from moderate to mild, from mild to none.
Lo.Li.Pharma s.r.l
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00006444
Blood-Borne Infections, Communicable Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01827423
Nasal Diseases, Nasal Polyps
Ostrava, Moravian-Silesian Region, Czechia
View Trial DetailsNCT00001126
Neoplasms, Neoplasms by Histologic Type
Birmingham, Alabama, United States
View Trial DetailsNCT00001603
Behavior, Carcinoma
Bethesda, Maryland, United States
View Trial Details